World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
24029
World Ranking
17088
National Ranking
563

Xavier Puéchal publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Xavier Puéchal sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 446 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Xavier Puéchal D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Xavier Puéchal sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Xavier Puéchal is affiliated with Université Paris Cité in France and has a significant body of research primarily in the field of Medicine, with a strong emphasis on Pulmonary and Respiratory Medicine, Rheumatology, Genetics, Physiology, and Immunology. Their scientific work involves key topics such as vasculitis and related conditions, coagulation processes, sarcoidosis, otitis media, urticaria, eosinophilic disorders, and Whipple's disease.

The research outputs by Xavier Puéchal include multiple notable publications spanning high-impact journals. Some recent papers are:

  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis, 2020, New England Journal of Medicine
  • Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, 2020, Annals of Internal Medicine
  • Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study, 2020, Arthritis & Rheumatology
  • French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides), 2020, Orphanet Journal of Rare Diseases
  • Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis, 2020, Clinical Journal of the American Society of Nephrology

Collaborative work features several frequent coauthors, including:

  • Benjamin Terrier
  • Loïc Guillevin
  • Luc Mouthon
  • Alexandre Karras
  • Pascal Cohen

Xavier Puéchal's publications often appear in recurring venues such as:

  • La Revue de Médecine Interne
  • Lara D. Veeken
  • Annals of the Rheumatic Diseases
  • Revue du Rhumatisme
  • Seminars in Arthritis and Rheumatism

The scientific investigation centers notably on vasculitis and related autoimmune conditions. The integration of genetics and immunology in their studies supports a multidisciplinary approach to complex systemic diseases. Research contributions also extend to coagulation pathways and disorders related to eosinophilic syndromes, reflecting a broad spectrum of clinical and biological inquiry.

Best Publications

  • Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

    Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier

  • Whipple's disease.

    Florence Fenollar;Xavier Puéchal;Didier Raoult

  • Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome

    Régis Sablé-Fourtassou;Pascal Cohen;Alfred Mahr;Christian Pagnoux

  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

    Michael Walsh;Peter A Merkel;Chen-Au Peh;Wladimir M Szpirt

  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin

  • Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

    Christian Pagnoux;Alfred Mahr;Mohamed A. Hamidou;Jean-Jacques Boffa

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

    Valérie Devauchelle-Pensec;Xavier Mariette;Sandrine Jousse-Joulin;Jean-Marie Berthelot

  • Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.

    Camillo Ribi;Pascal Cohen;Christian Pagnoux;Alfred Mahr

  • Vasculitides associated with malignancies: analysis of sixty patients.

    Olivier Fain;Mohamed Hamidou;Patrice Cacoub;Bertrand Godeau

  • Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

    Dominique Salmon-Céron;Florence Tubach;Olivier Lortholary;Olivier Chosidow

  • Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome: The JOQUER Randomized Clinical Trial

    Jacques-Eric Gottenberg;Philippe Ravaud;Xavier Puéchal;Véronique Le Guern

  • Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.

    Loïc Guillevin;Pascal Cohen;Alfred Mahr;Jean-Pierre Arène

  • Eprodisate for the treatment of renal disease in AA amyloidosis.

    Laura M. Dember;Philip N. Hawkins;Bouke P.C. Hazenberg;Peter D. Gorevic

  • Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

    Pierre Charles;Benjamin Terrier;Élodie Perrodeau;Pascal Cohen

  • Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

    Raphaèle Seror;Gabriel Baron;Eric Hachulla;Michel Debandt

  • EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

    Neil Basu;Richard Watts;Ingeborg Bajema;Bo Baslund

  • Long-term Outcomes of 118 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome) Enrolled in Two Prospective Trials

    Maxime Samson;Xavier Puéchal;Hervé Devilliers;Camillo Ribi

  • Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients.

    Xavier Puéchal;Gerard Said;Pascal Hilliquin;Joel Coste

Frequent Co-Authors

Loïc Guillevin
Loïc Guillevin Université Paris Cité
Luc Mouthon
Luc Mouthon Université Paris Cité
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Jean Sibilia
Jean Sibilia University of Strasbourg
Eric Hachulla
Eric Hachulla University of Lille
Philippe Ravaud
Philippe Ravaud Université Paris Cité
Olivier Fain
Olivier Fain Université Paris Cité
Maxime Dougados
Maxime Dougados Hôpital Cochin
Alfred Mahr
Alfred Mahr Université Paris Cité
Laure Gossec
Laure Gossec Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing careers in healthcare but not ready to commit to a traditional Medicine program, a variety of related online degrees offer flexible, cost-effective alternatives. Many students begin their path with affordable medical billing and coding programs, which provide a gateway into the administrative side of healthcare and can be completed quickly online.

Nursing is another popular option. Prospective nurses can explore what is the cheapest online college for nursing? to find programs that fit their budget and career goals. For those seeking advanced practice roles, it’s wise to consider the cheapest online acute care nurse practitioner programs, which prepare graduates for specialized patient care positions.

For nurses aiming for leadership, academia, or research, various online phd programs nursing are available at accessible price points, enabling working professionals to advance without leaving their current roles. These online healthcare degrees can pave the way for dynamic and rewarding career pathways beyond medical school.

Best Scientists Citing Xavier Puéchal

Trending Scientists

Recently Published Articles